Skin care brand Cannuka only came to market towards the end of last year, and already the company has received $750,000 in funding and seen 70 percent month-to-month growth in sales.
What’s the secret ingredient behind its success? Cannabis.
The brand’s products consist of a combination of CBD oils and manuka honey.
“CBD...is a very powerful anti-inflammatory...But we knew we needed to complement that with another ingredient,” explained Cannuka's Founder and CEO, Michael Bumgarner. “That’s when we found manuka honey, [which] is the most powerful antibacterial honey in the world.”
On top of the ingredients, Cannuka’s branding was designed to appeal to a wider market.
“We knew because we’re in the cannabis space we had to be approachable,” said Bumgarner. “It’s harder to explain the benefits because you have that stigma still about it.”
So far, Cannuka has been selling direct-to-consumer through its website but now wants to hit brick-and-mortar stores.
For the full interview, [click here](https://cheddar.com/videos/inside-the-power-of-cbd-for-skincare).
Al Root, Associate Editor at Barron's, joins to discuss Tesla’s robotaxis going live in Texas—what it means for autonomy, safety, and the EV race ahead.
Dena Jalbert, M&A expert and CEO of Align Business Advisory Services, on the state of U.S. M&A: deals worth $1–$10 billion (including debt) are surging.
Jeremy Jansen, Head of Supply Chain at Wells Fargo, unpacks the ongoing trade talks between the United States and China as consumers still wonder about tariffs.
IBM Fellow Jerry Chow talks IBM’s expansion of the Quantum Data Center in Poughkeepsie, installing Heron processors that deliver utility‑scale performance.
Ken Shepard, Head of Specialty Asset Management at Bank of America, discusses the importance of real assets and unpacks the bank's specialty asset outlook.
Cardinal Health's Debbie Weitzman explains how the company's Advanced Therapy Solutions Innovation Center aims to improve access to specialty medicines. Watch!
